000 | 01246 a2200325 4500 | ||
---|---|---|---|
005 | 20250516004635.0 | ||
264 | 0 | _c20110512 | |
008 | 201105s 0 0 eng d | ||
022 | _a1573-2665 | ||
024 | 7 |
_a10.1007/s10545-010-9219-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLinthorst, Gabor E | |
245 | 0 | 0 |
_aLetter concerning "Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha", by Tanaka et al. _h[electronic resource] |
260 |
_bJournal of inherited metabolic disease _cFeb 2011 |
||
300 |
_a237-8 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 |
_aAntibody Formation _xdrug effects |
650 | 0 | 4 | _aChoice Behavior |
650 | 0 | 4 | _aCross Reactions |
650 | 0 | 4 | _aEnzyme Replacement Therapy |
650 | 0 | 4 |
_aFabry Disease _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin E _xblood |
650 | 0 | 4 |
_aIsoenzymes _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aalpha-Galactosidase _ximmunology |
700 | 1 | _aAerts, Johannes M F G | |
773 | 0 |
_tJournal of inherited metabolic disease _gvol. 34 _gno. 1 _gp. 237-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10545-010-9219-y _zAvailable from publisher's website |
999 |
_c20242718 _d20242718 |